Medley Genomics looks to engineer cancer treatment, one tumor at a time

ACTIONABLE DATA: From left, Niru Chennagiri, director of informatics at Medley Genomics, and Patrice Milos, CEO, review notes on genetic information at the company’s Providence office. 
 / PBN PHOTO/RUPERT WHITELEY
ACTIONABLE DATA: From left, Niru Chennagiri, director of informatics at Medley Genomics, and Patrice Milos, CEO, review notes on genetic information at the company’s Providence office. 
 / PBN PHOTO/RUPERT WHITELEY
Innovative Companies | Biotechnology and Life Sciences We’ve all heard of data analytics. But what if this data could be used to treat what may well be the biggest medical beast of our time, cancer? Looking at tumors’ unique, individual composition to find information leading to lasting treatment is the work of Medley Genomics of…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -